FI935036A0 - 1H-Imidazol-1-yl-metyl-bensofuranderivat, daer imidazolylgruppen aer substituerade med cykloalkylgrupp - Google Patents
1H-Imidazol-1-yl-metyl-bensofuranderivat, daer imidazolylgruppen aer substituerade med cykloalkylgruppInfo
- Publication number
- FI935036A0 FI935036A0 FI935036A FI935036A FI935036A0 FI 935036 A0 FI935036 A0 FI 935036A0 FI 935036 A FI935036 A FI 935036A FI 935036 A FI935036 A FI 935036A FI 935036 A0 FI935036 A0 FI 935036A0
- Authority
- FI
- Finland
- Prior art keywords
- groups
- benzofurans
- imidazol
- substituted
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919110636A GB9110636D0 (en) | 1991-05-16 | 1991-05-16 | Chemical compounds |
| PCT/GB1992/000888 WO1992020674A1 (en) | 1991-05-16 | 1992-05-15 | 1h-imidazol-1-yl-methyl benzofuran derivatives, with the imidazolyl moiety being substituted by a cycloalkyl group |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI935036A0 true FI935036A0 (fi) | 1993-11-15 |
| FI935036A FI935036A (fi) | 1993-11-15 |
Family
ID=10695121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI935036A FI935036A (fi) | 1991-05-16 | 1993-11-15 | 1h-imidazol-1-yl-metyl-bensofuranderivat, daer imidazolylgruppen aer substituerade med cykloalkylgrupp |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US5332831A (de) |
| EP (1) | EP0514198B1 (de) |
| JP (1) | JPH06211846A (de) |
| KR (1) | KR920021541A (de) |
| AP (1) | AP318A (de) |
| AT (1) | ATE169297T1 (de) |
| AU (2) | AU654350B2 (de) |
| BG (1) | BG98216A (de) |
| CA (1) | CA2068766A1 (de) |
| CZ (1) | CZ243093A3 (de) |
| DE (1) | DE69226472D1 (de) |
| FI (1) | FI935036A (de) |
| GB (1) | GB9110636D0 (de) |
| IL (1) | IL101882A0 (de) |
| IS (1) | IS1609B (de) |
| MX (1) | MX9202281A (de) |
| NO (1) | NO921944L (de) |
| OA (1) | OA09841A (de) |
| SK (1) | SK112893A3 (de) |
| TW (1) | TW221998B (de) |
| WO (1) | WO1992020674A1 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9218449D0 (en) | 1992-08-29 | 1992-10-14 | Boots Co Plc | Therapeutic agents |
| US5336779A (en) * | 1992-10-08 | 1994-08-09 | Nippon Gohsei Kagaku Kogyo Kabushiki Kaisha | Method of producing formylimidazoles |
| EP0853477B1 (de) * | 1995-10-06 | 2002-10-09 | Novartis AG | Ati-rezeptorantagonisten zur verhinderung und behandlung des postischemischen nervenversagens und zum schutze ischemischer nieren |
| WO1997031634A1 (en) | 1996-02-29 | 1997-09-04 | Novartis Ag | At1 receptor antagonist for the stimulation of apoptosis |
| KR100567183B1 (ko) * | 1997-11-14 | 2006-06-13 | 론자 아게 | 포르밀이미다졸의제조방법 |
| CA2351357A1 (en) | 1998-12-23 | 2000-07-06 | Novartis Ag | Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| US6465502B1 (en) | 1998-12-23 | 2002-10-15 | Novartis Ag | Additional therapeutic use |
| CN101011390A (zh) | 1999-01-26 | 2007-08-08 | 诺瓦提斯公司 | 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用 |
| US6211217B1 (en) | 1999-03-16 | 2001-04-03 | Novartis Ag | Method for reducing pericardial fibrosis and adhesion formation |
| WO2001005428A1 (fr) * | 1999-07-21 | 2001-01-25 | Takeda Chemical Industries, Ltd. | Methodes preventives contre la recurrence d'une insuffisance cerebrovasculaire, et agents destines a ameliorer des troubles causes par une insuffisance cerebrovasculaire et a inhiber leur evolution |
| SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| WO2002013821A1 (en) * | 2000-08-17 | 2002-02-21 | Gliatech, Inc. | Novel alicyclic imidazoles as h3 agents |
| DE10335027A1 (de) | 2003-07-31 | 2005-02-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von Angiotensin II Rezeptor Antagonisten |
| KR101397289B1 (ko) * | 2006-05-05 | 2014-05-22 | 다우 글로벌 테크놀로지스 엘엘씨 | 헤테로시클릭 유기 리간드의 하프늄 착물 |
| WO2008029825A1 (fr) | 2006-09-05 | 2008-03-13 | Kyowa Hakko Kirin Co., Ltd. | Dérivé d'imidazole |
| EP1908469A1 (de) | 2006-10-06 | 2008-04-09 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin II Rezeptor Antagonisten zur Behandlung von systemischen Krankheiten bei Katzen |
| JP5072675B2 (ja) | 2007-04-03 | 2012-11-14 | 四国化成工業株式会社 | ２−ハロイミダゾール化合物の製造方法 |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| CA3089569C (en) | 2007-06-04 | 2023-12-05 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| EP2970384A1 (de) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonisten der guanylatcyclase und deren verwendungen |
| JP2016514670A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト |
| RS65632B1 (sr) | 2013-06-05 | 2024-07-31 | Bausch Health Ireland Ltd | Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe |
| DK3648761T3 (da) | 2017-07-07 | 2024-06-24 | Boehringer Ingelheim Vetmedica Gmbh | Telmisartan til forebyggelsen eller behandlingen af hypertension i katte |
| CN110256382A (zh) * | 2019-06-06 | 2019-09-20 | 武汉药明康德新药开发有限公司 | 一种2-(5-甲基苯并呋喃-2-基)苯甲腈的合成方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1389827A (en) * | 1971-07-23 | 1975-04-09 | Fisons Ltd | Tetrazolyl benzopyrans |
| JPS54148788A (en) * | 1978-05-15 | 1979-11-21 | Takeda Chem Ind Ltd | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative and its preparation |
| US4526896A (en) * | 1978-12-26 | 1985-07-02 | Riker Laboratories, Inc. | Tetrazol-5-yl 2-nitro-3-phenylbenzofurans and antimicrobial use thereof |
| JPS5671074A (en) * | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative |
| JPS5671073A (en) * | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | Imidazole derivative |
| AU559687B2 (en) * | 1981-07-01 | 1987-03-19 | Upjohn Company, The | Pyridinyl-and imidazolyl-benzofurane and benzothiophenes |
| JPS6163671A (ja) * | 1984-09-05 | 1986-04-01 | Shionogi & Co Ltd | ２，３−ジヒドロベンゾフラン−５−スルホンアミド誘導体および降圧利尿剤 |
| CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
| US4916129A (en) * | 1989-01-19 | 1990-04-10 | E. I. Du Pont De Nemours And Company | Combination β-blocking/angiotensin II blocking antihypertensives |
| DE10075018I2 (de) * | 1989-06-14 | 2001-08-09 | Smithkline Beecham Corp | Imidazoalkensäure. |
| SG50669A1 (en) * | 1989-06-30 | 1998-07-20 | Du Pont | Fused-ring aryl subtituted imidazoles |
| WO1991000277A1 (en) * | 1989-06-30 | 1991-01-10 | E.I. Du Pont De Nemours And Company | Substituted imidazoles |
| JPH03204875A (ja) * | 1989-10-03 | 1991-09-06 | Wakamoto Pharmaceut Co Ltd | テトラゾール酢酸誘導体、及び該誘導体を有効成分とするアルドースレダクターゼ阻害剤 |
| AU640417B2 (en) * | 1989-10-25 | 1993-08-26 | Smithkline Beecham Corporation | Substituted 5-((tetrazolyl)alkenyl)imidazoles |
| CA2028925A1 (en) * | 1989-11-06 | 1991-05-07 | Gerald R. Girard | Substituted n-(imidazolyl)alkyl alanine derivatives |
| GB8927277D0 (en) * | 1989-12-01 | 1990-01-31 | Glaxo Group Ltd | Chemical compounds |
| US5190942A (en) * | 1991-04-22 | 1993-03-02 | E. R. Squibb & Sons, Inc. | Benzoxazole and related heterocyclic substituted imidazole and benzimidazole derivatives |
| NO921951L (no) * | 1991-05-16 | 1992-11-17 | Glaxo Group Ltd | Benzofuran-derivater |
| DE4140519A1 (de) * | 1991-12-09 | 1993-06-17 | Merck Patent Gmbh | Benzofurane |
-
1991
- 1991-05-16 GB GB919110636A patent/GB9110636D0/en active Pending
-
1992
- 1992-05-15 CZ CS932430A patent/CZ243093A3/cs unknown
- 1992-05-15 KR KR1019920008241A patent/KR920021541A/ko not_active Application Discontinuation
- 1992-05-15 AT AT92304420T patent/ATE169297T1/de not_active IP Right Cessation
- 1992-05-15 SK SK1128-93A patent/SK112893A3/sk unknown
- 1992-05-15 JP JP4148890A patent/JPH06211846A/ja active Pending
- 1992-05-15 IS IS3865A patent/IS1609B/is unknown
- 1992-05-15 AU AU16321/92A patent/AU654350B2/en not_active Ceased
- 1992-05-15 TW TW081103782A patent/TW221998B/zh active
- 1992-05-15 CA CA002068766A patent/CA2068766A1/en not_active Abandoned
- 1992-05-15 WO PCT/GB1992/000888 patent/WO1992020674A1/en not_active Application Discontinuation
- 1992-05-15 EP EP92304420A patent/EP0514198B1/de not_active Expired - Lifetime
- 1992-05-15 DE DE69226472T patent/DE69226472D1/de not_active Expired - Lifetime
- 1992-05-15 MX MX9202281A patent/MX9202281A/es unknown
- 1992-05-15 US US07/883,378 patent/US5332831A/en not_active Expired - Fee Related
- 1992-05-15 AP AP9200389A patent/AP318A/en active
- 1992-05-15 NO NO92921944A patent/NO921944L/no unknown
- 1992-05-15 AU AU16926/92A patent/AU1692692A/en not_active Abandoned
- 1992-05-15 IL IL101882A patent/IL101882A0/xx unknown
-
1993
- 1993-10-08 OA OA60424A patent/OA09841A/en unknown
- 1993-11-12 BG BG98216A patent/BG98216A/xx unknown
- 1993-11-15 FI FI935036A patent/FI935036A/fi not_active Application Discontinuation
-
1994
- 1994-03-31 US US08/220,698 patent/US5498722A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL101882A0 (en) | 1992-12-30 |
| NO921944D0 (no) | 1992-05-15 |
| EP0514198A1 (de) | 1992-11-19 |
| US5332831A (en) | 1994-07-26 |
| ATE169297T1 (de) | 1998-08-15 |
| KR920021541A (ko) | 1992-12-18 |
| CZ243093A3 (en) | 1994-03-16 |
| GB9110636D0 (en) | 1991-07-03 |
| CA2068766A1 (en) | 1992-11-17 |
| OA09841A (en) | 1994-08-15 |
| AP318A (en) | 1994-02-15 |
| AU1692692A (en) | 1992-12-30 |
| FI935036A (fi) | 1993-11-15 |
| JPH06211846A (ja) | 1994-08-02 |
| EP0514198B1 (de) | 1998-08-05 |
| IS1609B (is) | 1996-10-18 |
| AU1632192A (en) | 1993-03-11 |
| DE69226472D1 (de) | 1998-09-10 |
| MX9202281A (es) | 1992-11-01 |
| BG98216A (en) | 1994-08-15 |
| US5498722A (en) | 1996-03-12 |
| WO1992020674A1 (en) | 1992-11-26 |
| SK112893A3 (en) | 1994-11-09 |
| NO921944L (no) | 1992-11-17 |
| AU654350B2 (en) | 1994-11-03 |
| IS3865A (is) | 1992-11-17 |
| TW221998B (de) | 1994-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI935036A0 (fi) | 1H-Imidazol-1-yl-metyl-bensofuranderivat, daer imidazolylgruppen aer substituerade med cykloalkylgrupp | |
| FI935194A (fi) | Foerfarande foer dubbelriktad oeverfoering i ett cellulaert mobilradiokommunikationssystem, i vilket foerfarande olika basstationer anvaends foer downlink- och uplink-foerbindelse | |
| FI921708A (fi) | Stolstoppning, speciellt flygplansfaotoelj | |
| FI922494A (fi) | Pulverformig, enzymer innehaollande diskmedelskomposition foer automatiska diskmaskiner | |
| FI923969A0 (fi) | Adaptiv foerdelning av resurser i ett mobiltelefonsystem. | |
| FI924709A0 (fi) | Pao hartsemulsion baserat ytlimningsmedel, ett daermed limmat papper ochett limningsfoerfarande foer utnyttjande daerav | |
| FI910212A (fi) | Foerstaerkningsreglering av en agc -foerstaerkare i ett pao tidsmultiplexering baserat radiotelefonsystem. | |
| DE69222122D1 (de) | Schwingungsregelsystem | |
| DE69206268D1 (de) | Modellunterstüztes regelungssystem. | |
| DE69201421D1 (de) | Systemsteuerungen. | |
| FI921361A0 (fi) | Lagerhus foer ett flerradigt rullager. | |
| DE59201507D1 (de) | Federungssystem. | |
| FI922654A (fi) | Saekringsanordning foer avtryckarmekanismer, isynnerhet foer eldvapen | |
| NO912312D0 (no) | Styresystem. | |
| NL194743B (nl) | Regelstelsel. | |
| FI924361A0 (fi) | Identifikationsbaermedel foer ett tillslutningssystem. | |
| FI925411A0 (fi) | Fartyg, speciellt handelsfartyg | |
| FI915179A0 (fi) | Digitaldetektor foer ett soekaranlaeggningsystem. | |
| FI921759A (fi) | Lineaer viskoelastisk vattenhaltig flytande detergentkomposition, speciellt foer automatiska diskmaskiner | |
| FI924395A (fi) | Icke-a, icke-b-peptider | |
| FI923542A (fi) | Faestanordning foer klingor, isynnerhet i bestrykningsmaskiner | |
| FI922490A (fi) | Vattenfri, flytande, enzymer innehaollande diskmedelskomposition foer automatiska diskmaskiner | |
| FI912669A0 (fi) | Dubbleringsfoerfarande foer ett kopplingssystem, speciellt foer en telefoncentral. | |
| FI911861A0 (fi) | Byggnad, vari yttervaegg aer foersedd med ett isoleringsskikt. | |
| FI922501A0 (fi) | Vattenhaltig vaetskeformig tvaett- medelskomposition innehaollande ett polymert foertjockningsmedel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |